Summary
| Name | pralatrexate
|
| Synonyms | (2S)-2-((4-((1RS)-1-((2,4-Diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic acid (ChemIDplus), (2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}amino)pentanedioic acid (IUPAC), 10-Propargyl-10-deazaaminopterin (KEGG DRUG), Folotyn (ChemIDplus), HSDB 7786 (ChemIDplus), N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid (ChemIDplus), pralatrexate (WHO MedNet), pralatrexate (KEGG DRUG), pralatrexato (WHO MedNet), pralatrexatum (WHO MedNet) |
| IUPAC | N-{4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic acid |
| Formula | C23H23N7O5 |
| PRIMARY ID (Read more) |
CHEBI:71223![]() |
| Type | chemical |
| Relations | 3 |
Viewer
Search Tools
Refine search:
- by mechanism
- by effect
- by organism:
- by tissue:
- by cell-line
Relations
| Regulator | Mechanism | target | score ℹ | |
|---|---|---|---|---|
| + | pralatrexate | down-regulates activity
chemical inhibition
|
DHFR | 0.8 |
| Publications: | 2 | Organism: | Homo Sapiens | |
| + | pralatrexate | down-regulates activity
chemical inhibition
|
TYMS | 0.8 |
| Publications: | 1 | Organism: | Homo Sapiens | |
4.0
pralatrexate

chemical inhibition